Utah Medical Products, Inc. filed its 2025 Proxy Card, outlining proposals for its Annual Meeting of Stockholders scheduled for May 2, 2025. Among the key items for stockholder vote is the election of one director to serve a three-year term.
The proxy statement proposes the election of Carrie Leigh as a director. This formalizes the process for her appointment to the Board of Directors, following her prior announcement.
Shareholders will also vote on other proposals, including the ratification of Haynie & Company as the independent public accounting firm for 2025 and an advisory vote on the company's executive compensation program. These items are crucial for corporate governance and financial oversight.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.